Drug Database
Back to search

Finland· FI-REL-REL47093

Enzepi

A multienzyme - lipase, protease etc product containing pancreas powder, registered in Finland by Allergan Pharmaceuticals International Ltd. The same ATC class is registered in 11 of our 19 countries.

ATC A09AA02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedEnzepiATCA09AA02REGISTER NO.FI-REL-REL47093PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pancreas powderAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Multienzyme - lipase, protease etc is registered in 11 of 19 countries.

Countries holding a registration under ATC A09AA02 (multienzyme - lipase, protease etc), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search multienzyme - lipase, protease etc products by name

Multienzyme - lipase, protease etc · ATC A09AA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Pancreas powder
Manufacturer
Allergan Pharmaceuticals International Ltd
Country
Finland (FI)
ATC code
A09AA02
ATC class
Multienzyme - Lipase, Protease etc
Defined daily dose
240 TSD, FIP
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for multienzyme - lipase, protease etc.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check multienzyme - lipase, protease etc against other medicinesHow interaction checks work

Multienzyme - lipase, protease etc · interactions on record

20 records

  • 20 moderate

Most severe, free to view

  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Calcium carbonateA02AC01moderate
  • MagaldrateA02AD02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Multienzyme - lipase, protease etc in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All multienzyme - lipase, protease etc products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Kreon, Kreon – Kapseln
  • Belgium · Ankreta, Creon
  • Bulgaria · Креон
  • Cyprus · Creon
  • Czechia · Kreon, Pancreolan Forte 6000
  • Germany · Kreon, Pancrin
  • Denmark · Creon
  • Estonia · Kreon, Mezym
  • Spain · Kreon
  • France · Creon
  • United Kingdom (Northern Ireland) · Creon, Creon Micro
  • Greece · Creon, Creon-P
  • Croatia · Kreon, Pangrol
  • Hungary · Dipankrin Optimum, Kreon
  • Ireland · Creon, Creon For Children
  • Iceland · Creon
  • Italy · Creon, Creonipe
  • Lithuania · Kreon, Pangrol
  • Luxembourg · Ankreta, Creon
  • Latvia · Kreon, Pangrol
  • Malta · Creon
  • Netherlands · Creon, Micrazym
  • Norway · Creon
  • Poland · Kreon, Kreon 25 000
  • Portugal · Kreon, Kreon 25000
  • Romania · Kreon, Mezym
  • Sweden · Creon, Micrazym
  • Slovenia · Kreon, Kreon Epi
  • Slovakia · Kreon, Pancreolan Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e326ad1b-64e9-47b2-9986-4e1db419a822
GET /v1/drugs/e326ad1b-64e9-47b2-9986-4e1db419a822?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "enterokapseli, kova",
  "route": null,
  "ddd_unit": null,
  "strength": "40000 U",
  "atc_label": "useita entsyymejä (lipaasi, proteaasi jne.) sisältävät valmisteet",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/16/1113/13-16",
  "fimea_rel_id": "REL47093",
  "authorised_at": "2016-06-29"
}
API referenceMCP serverPlans

See everything about multienzyme - lipase, protease etc.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console